Innovative Clinical Trial Evaluates Bioengineered Palate Mucosa for Cleft Palate Treatment in Children

Posted: December 5, 2024
This groundbreaking Phase I-IIa clinical trial aims to assess the safety, feasibility, and efficacy of utilizing a bioengineered artificial palate mucosa for treating children with cleft palate. The study involves grafting bioartificial palate mucosa onto bone areas during uranostaphylorrhaphy surgery. The innovative approach utilizes tissue engineering with autologous cells and biomaterials to potentially improve treatment outcomes and reduce postoperative complications. The research will evaluate biosafety, graft evolution, and patient factors over a 2-year follow-up period, with a focus on craniomaxillofacial development, speech capability, and quality of life. Approved by ethical and regulatory bodies, this study holds promise for advancing cleft palate treatment methods.

This article summary was generated by AI. To view the full article, click the link here: https://pubmed.ncbi.nlm.nih.gov/39638596/
Views: 1
Sponsors
Townie Perks
Townie® Poll
Who or what do you turn to for most financial advice regarding your practice?
  
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@farranmedia.com
©2025 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450